Aceragen (Acquired) Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 30

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 1

Aceragen (Acquired) General Information

Description

Operator of a rare disease biopharmaceutical company focused on developing novel therapies which can have a positive impact on the lives of patients and families. The company address rare, orphan diseases that typically have no available treatment, and provide rare disease patients with compelling new therapeutic options that will allow them to lead the fullest lives possible.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 15 TW Alexander Drive
  • Durham, NC 27709
  • United States
Primary Industry
Drug Discovery
Acquirer
Aceragen
Corporate Office
  • 15 TW Alexander Drive
  • Durham, NC 27709
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aceragen (Acquired) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aceragen (Acquired)‘s full profile, request access.

Request a free trial

Aceragen (Acquired) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a rare disease biopharmaceutical company focused on developing novel therapies which can have a positive imp
Drug Discovery
Durham, NC
30 As of 2022

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aceragen (Acquired) Competitors (1)

One of Aceragen (Acquired)’s competitors is Mission Therapeutics, a Venture Capital-Backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mission Therapeutics Venture Capital-Backed Cambridge, United Kingdom
You’re viewing 1 of 1 competitors. Get the full list »

Aceragen (Acquired) Patents

  • 1,381

    Total Documents Applications and Grants

  • Total Patents Families

  • 285

    Granted

  • 29

    Pending

  • Expiring in next 12 mo

Aceragen (Acquired) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2023128726-A Tlr9 modulators for treating cancer Pending 04-Mar-2022
AU-2022201046-A1 Tlr9 modulators for treating cancer Inactive 17-Feb-2022
CA-3148401-A1 Tlr9 modulators for treating cancer Pending 10-Feb-2022
US-20210317454-A1 Use of a tlr9 agonist in methods for treating covid-19 Inactive 10-Apr-2020
WO-2021207653-A1 Use of a tlr9 agonist in methods for treating covid-19 Inactive 10-Apr-2020 A61P31/14
To view Aceragen (Acquired)’s complete patent history, request access »

Aceragen (Acquired) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aceragen (Acquired) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Aceragen (Acquired)‘s full profile, request access.

Request a free trial

Aceragen (Acquired) Investments (1)

Aceragen (Acquired)’s most recent deal was a Buyout/LBO with Arrevus. The deal was made on 25-Oct-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Arrevus 25-Oct-2021 Buyout/LBO Drug Discovery
To view Aceragen (Acquired)’s complete investments history, request access »

Aceragen (Acquired) FAQs

  • When was Aceragen (Acquired) founded?

    Aceragen (Acquired) was founded in 2021.

  • Where is Aceragen (Acquired) headquartered?

    Aceragen (Acquired) is headquartered in Durham, NC.

  • What is the size of Aceragen (Acquired)?

    Aceragen (Acquired) has 30 total employees.

  • What industry is Aceragen (Acquired) in?

    Aceragen (Acquired)’s primary industry is Drug Discovery.

  • Is Aceragen (Acquired) a private or public company?

    Aceragen (Acquired) is a Private company.

  • What is the current valuation of Aceragen (Acquired)?

    The current valuation of Aceragen (Acquired) is .

  • What is Aceragen (Acquired)’s current revenue?

    The current revenue for Aceragen (Acquired) is .

  • How much funding has Aceragen (Acquired) raised over time?

    Aceragen (Acquired) has raised $70M.

  • Who are Aceragen (Acquired)’s investors?

    Arrevus and NovaQuest Capital Management have invested in Aceragen (Acquired).

  • Who are Aceragen (Acquired)’s competitors?

    Mission Therapeutics is a competitor of Aceragen (Acquired).

  • When was Aceragen (Acquired) acquired?

    Aceragen (Acquired) was acquired on 28-Sep-2022.

  • Who acquired Aceragen (Acquired)?

    Aceragen (Acquired) was acquired by Aceragen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process